Biological mechanisms and cardiovascular effects of omega-3 fatty acids

B. A. Mueller, Robert Talbert

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The mechanisms and cardiovascular effects of omega-3 fatty acids are reviewed. Omega-3 polyunsaturated fatty acids are the major ingredient found in commercially available fish oil products. The incidence of many diseases, including coronary heart disease, diabetes mellitus, and psoriasis, is lower in Eskimos, who ingest diets rich in omega-3 fatty acids, compared with European controls. Potential mechanisms by which these fatty acids cause their many physiologic effects include competing with omega-6 fatty acids for prostaglandin and leukotriene pathways and enhancing cell membrane fluidity by virtue of the high degree of unsaturation. Numerous studies have documented longer bleeding times and decreased platelet aggregation in subjects ingesting omega-3 fatty acids. Omega-3 fatty acids may reduce serum cholesterol concentrations by decreasing the synthesis of very low density lipoprotein and, therefore, low-density lipoprotein. Blood viscosity is significantly and uniformly lower in subjects receiving omega-3 fatty acids compared with controls. Potential risks of supplementation with fish oils include hypervitaminosis A and D, vitamin E deficiency, increased bleeding times, decreased platelets, and ingestion of contaminated fish. Supplementation with moderate amounts of omega-3 fatty acids appears to be relatively safe. Possible adverse effects include nausea, diarrhea, and a 'fishy' taste. Properly controlled, long-term clinical trials are needed to determine whether supplementation with omega-3 fatty acids would be therapeutically beneficial in various patient populations and disease states.

Original languageEnglish (US)
Pages (from-to)795-807
Number of pages13
JournalClinical Pharmacy
Volume7
Issue number11
StatePublished - 1988
Externally publishedYes

Fingerprint

Omega-3 Fatty Acids
Bleeding Time
Fish Oils
Hypervitaminosis A
Omega-6 Fatty Acids
Vitamin E Deficiency
Fish Products
Inuits
Blood Viscosity
Membrane Fluidity
VLDL Lipoproteins
Leukotrienes
Unsaturated Fatty Acids
Platelet Aggregation
LDL Lipoproteins
Psoriasis
Nausea
Prostaglandins
Coronary Disease
Diarrhea

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Biological mechanisms and cardiovascular effects of omega-3 fatty acids. / Mueller, B. A.; Talbert, Robert.

In: Clinical Pharmacy, Vol. 7, No. 11, 1988, p. 795-807.

Research output: Contribution to journalArticle

Mueller, BA & Talbert, R 1988, 'Biological mechanisms and cardiovascular effects of omega-3 fatty acids', Clinical Pharmacy, vol. 7, no. 11, pp. 795-807.
Mueller, B. A. ; Talbert, Robert. / Biological mechanisms and cardiovascular effects of omega-3 fatty acids. In: Clinical Pharmacy. 1988 ; Vol. 7, No. 11. pp. 795-807.
@article{74088422ff914b899e08d9ce13934ec2,
title = "Biological mechanisms and cardiovascular effects of omega-3 fatty acids",
abstract = "The mechanisms and cardiovascular effects of omega-3 fatty acids are reviewed. Omega-3 polyunsaturated fatty acids are the major ingredient found in commercially available fish oil products. The incidence of many diseases, including coronary heart disease, diabetes mellitus, and psoriasis, is lower in Eskimos, who ingest diets rich in omega-3 fatty acids, compared with European controls. Potential mechanisms by which these fatty acids cause their many physiologic effects include competing with omega-6 fatty acids for prostaglandin and leukotriene pathways and enhancing cell membrane fluidity by virtue of the high degree of unsaturation. Numerous studies have documented longer bleeding times and decreased platelet aggregation in subjects ingesting omega-3 fatty acids. Omega-3 fatty acids may reduce serum cholesterol concentrations by decreasing the synthesis of very low density lipoprotein and, therefore, low-density lipoprotein. Blood viscosity is significantly and uniformly lower in subjects receiving omega-3 fatty acids compared with controls. Potential risks of supplementation with fish oils include hypervitaminosis A and D, vitamin E deficiency, increased bleeding times, decreased platelets, and ingestion of contaminated fish. Supplementation with moderate amounts of omega-3 fatty acids appears to be relatively safe. Possible adverse effects include nausea, diarrhea, and a 'fishy' taste. Properly controlled, long-term clinical trials are needed to determine whether supplementation with omega-3 fatty acids would be therapeutically beneficial in various patient populations and disease states.",
author = "Mueller, {B. A.} and Robert Talbert",
year = "1988",
language = "English (US)",
volume = "7",
pages = "795--807",
journal = "Clinical Pharmacy",
issn = "0278-2677",
publisher = "American Society of Hospital Pharmacists",
number = "11",

}

TY - JOUR

T1 - Biological mechanisms and cardiovascular effects of omega-3 fatty acids

AU - Mueller, B. A.

AU - Talbert, Robert

PY - 1988

Y1 - 1988

N2 - The mechanisms and cardiovascular effects of omega-3 fatty acids are reviewed. Omega-3 polyunsaturated fatty acids are the major ingredient found in commercially available fish oil products. The incidence of many diseases, including coronary heart disease, diabetes mellitus, and psoriasis, is lower in Eskimos, who ingest diets rich in omega-3 fatty acids, compared with European controls. Potential mechanisms by which these fatty acids cause their many physiologic effects include competing with omega-6 fatty acids for prostaglandin and leukotriene pathways and enhancing cell membrane fluidity by virtue of the high degree of unsaturation. Numerous studies have documented longer bleeding times and decreased platelet aggregation in subjects ingesting omega-3 fatty acids. Omega-3 fatty acids may reduce serum cholesterol concentrations by decreasing the synthesis of very low density lipoprotein and, therefore, low-density lipoprotein. Blood viscosity is significantly and uniformly lower in subjects receiving omega-3 fatty acids compared with controls. Potential risks of supplementation with fish oils include hypervitaminosis A and D, vitamin E deficiency, increased bleeding times, decreased platelets, and ingestion of contaminated fish. Supplementation with moderate amounts of omega-3 fatty acids appears to be relatively safe. Possible adverse effects include nausea, diarrhea, and a 'fishy' taste. Properly controlled, long-term clinical trials are needed to determine whether supplementation with omega-3 fatty acids would be therapeutically beneficial in various patient populations and disease states.

AB - The mechanisms and cardiovascular effects of omega-3 fatty acids are reviewed. Omega-3 polyunsaturated fatty acids are the major ingredient found in commercially available fish oil products. The incidence of many diseases, including coronary heart disease, diabetes mellitus, and psoriasis, is lower in Eskimos, who ingest diets rich in omega-3 fatty acids, compared with European controls. Potential mechanisms by which these fatty acids cause their many physiologic effects include competing with omega-6 fatty acids for prostaglandin and leukotriene pathways and enhancing cell membrane fluidity by virtue of the high degree of unsaturation. Numerous studies have documented longer bleeding times and decreased platelet aggregation in subjects ingesting omega-3 fatty acids. Omega-3 fatty acids may reduce serum cholesterol concentrations by decreasing the synthesis of very low density lipoprotein and, therefore, low-density lipoprotein. Blood viscosity is significantly and uniformly lower in subjects receiving omega-3 fatty acids compared with controls. Potential risks of supplementation with fish oils include hypervitaminosis A and D, vitamin E deficiency, increased bleeding times, decreased platelets, and ingestion of contaminated fish. Supplementation with moderate amounts of omega-3 fatty acids appears to be relatively safe. Possible adverse effects include nausea, diarrhea, and a 'fishy' taste. Properly controlled, long-term clinical trials are needed to determine whether supplementation with omega-3 fatty acids would be therapeutically beneficial in various patient populations and disease states.

UR - http://www.scopus.com/inward/record.url?scp=0023697253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023697253&partnerID=8YFLogxK

M3 - Article

C2 - 3058376

AN - SCOPUS:0023697253

VL - 7

SP - 795

EP - 807

JO - Clinical Pharmacy

JF - Clinical Pharmacy

SN - 0278-2677

IS - 11

ER -